Deutsche Bank keeps Hold on Siemens Healthineers stock
Published on 10/07/2026 at 10:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Siemens Healthineers (ISIN DE000SHL1006) stock was trading at EUR 38.30 at Lang & Schwarz on October 7, 2026 at 10:16 a.m. CEST, up 1.43 percent versus the prior close of EUR 37.76. Deutsche Bank Research kept its Hold rating and EUR 39.00 price target on October 5, 2026, according to finanzen.ch.
Deutsche Bank stays cautious
The analyst update came ahead of Siemens Healthineers' fiscal fourth-quarter results. Deutsche Bank expects solid results but points to weak profitability and a new fiscal 2027 outlook as key issues, while its EUR 39.00 target sits only EUR 0.70 above the Lang & Schwarz reference price.
The rating matters because the company is balancing lower revenue momentum against tariff-related earnings support. The Hold stance therefore leaves the share close to the bank's stated valuation benchmark rather than signaling a change in its view.
Diagnostics drives the guidance cut
In the fiscal third quarter of 2026, Siemens Healthineers lowered its revenue growth outlook for fiscal 2026 to 3.50-4.00 percent from 4.50-5.00 percent. The Q3 earnings-call transcript attributes the change mainly to continued weakness in Diagnostics, especially in China and legacy platforms, as reported by Yahoo Finance on July 31, 2026.
The same call showed a more resilient operating picture elsewhere. Equipment book-to-bill reached 1.27 in the fiscal third quarter, while Precision Therapy grew 9.00 percent and Imaging and Precision Therapy together grew 5.00 percent. Adjusted earnings per share guidance for fiscal 2026 was raised to EUR 2.35-2.45 because of tariff refunds, partially offsetting the weaker revenue outlook.
Fourth-quarter results are next
Investors now have a dated checkpoint for the revised outlook. Siemens Healthineers lists fourth-quarter results and the analyst call for November 5, 2026, on its Siemens Healthineers investor-relations page.
For the stock, the central comparison is now between improving equipment demand and the Diagnostics drag. Investing.com reports fiscal third-quarter revenue of EUR 5.76 billion and earnings per share of EUR 0.70 versus EUR 0.53 expected, reinforcing the gap between operational earnings support and softer top-line growth, according to Investing.com.
Stock rises within its annual range
At Lang & Schwarz, the EUR 38.30 intraday price on October 7, 2026 stood EUR 0.54 above the EUR 37.76 prior close. The 52-week range runs from EUR 32.81 to EUR 49.71, placing the share EUR 11.41 below its annual high and EUR 5.49 above its annual low.
Siemens Healthineers had a market capitalization of EUR 42.9 billion as of October 7, 2026. The company is listed on Xetra under ticker SHL, and its next reporting date is November 5, 2026.
The further course of trading is shown by the continuously updated real-time quote of Siemens Healthineers stock.
Siemens Healthineers stock facts
- Company: Siemens Healthineers AG
- ISIN: DE000SHL1006
- WKN: SHL100
- Ticker: SHL
- Primary exchange: Xetra
- Price Lang & Schwarz as of October 7, 2026 at 10:16 a.m. CEST: EUR 38.30
- Change versus prior close: plus 1.43 percent
- Prior close Lang & Schwarz October 6, 2026: EUR 37.76
- Market capitalization: EUR 42.9 billion (as of October 7, 2026)
- 52-week range: EUR 32.81-49.71 (as of October 7, 2026)
- Sector / Industry: Healthcare / Healthcare Equipment and Supplies
- Next earnings date: November 5, 2026
